Search Results - "Lichter, Peter"
-
1
Chromothripsis in cancer cells: An update
Published in International journal of cancer (15-05-2016)“…In 2011, a novel form of genome instability was reported by Stephens et al., characterized by tens to hundreds of locally clustered rearrangements affecting…”
Get full text
Journal Article -
2
Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis
Published in Cancer cell (15-04-2019)“…We studied how intratumoral genetic heterogeneity shapes tumor growth and therapy response for isocitrate dehydrogenase (IDH)-wild-type glioblastoma, a rapidly…”
Get full text
Journal Article -
3
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Published in Cancer cell (11-11-2013)“…Two recurrent mutations, K27M and G34R/V, within histone variant H3.3 were recently identified in ∼50% of pHGGs. Both mutations define clinically and…”
Get full text
Journal Article -
4
Time-resolved, integrated analysis of clonally evolving genomes
Published in PLoS genetics (01-12-2023)“…Clonal genome evolution is a key feature of asexually reproducing species and human cancer development. While many studies have described the landscapes of…”
Get full text
Journal Article -
5
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
Published in Nature genetics (01-03-2016)“…Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription…”
Get full text
Journal Article -
6
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
Published in Nature (London) (26-06-2014)“…Medulloblastoma is a malignant childhood brain tumour presenting major clinical challenges; here, a comprehensive genome-wide DNA methylation data set from…”
Get full text
Journal Article -
7
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
Published in Acta neuropathologica (01-09-2012)“…Pediatric glioblastomas (GBM) including diffuse intrinsic pontine gliomas (DIPG) are devastating brain tumors with no effective therapy. Here, we investigated…”
Get full text
Journal Article -
8
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Published in Acta neuropathologica (01-04-2012)“…Medulloblastoma is the most common malignant brain tumor in childhood. Molecular studies from several groups around the world demonstrated that medulloblastoma…”
Get full text
Journal Article -
9
miRNA-130a Targets ATG2B and DICER1 to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells
Published in Cancer research (Chicago, Ill.) (01-04-2012)“…Toxicity and relapses from the immunochemotherapy used to treat chronic lymphocytic leukemia (CLL) prompt continued interest in gentle but effective targeted…”
Get full text
Journal Article -
10
Elastic SCAD as a novel penalization method for SVM classification tasks in high-dimensional data
Published in BMC bioinformatics (09-05-2011)“…Classification and variable selection play an important role in knowledge discovery in high-dimensional data. Although Support Vector Machine (SVM) algorithms…”
Get full text
Journal Article -
11
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Published in Nature communications (18-12-2020)“…Glioblastoma frequently exhibits therapy-associated subtype transitions to mesenchymal phenotypes with adverse prognosis. Here, we perform multi-omic profiling…”
Get full text
Journal Article -
12
MAPK pathway activation in pilocytic astrocytoma
Published in Cellular and molecular life sciences : CMLS (01-06-2012)“…Pilocytic astrocytoma (PA) is the most common tumor of the pediatric central nervous system (CNS). A body of research over recent years has demonstrated a key…”
Get full text
Journal Article -
13
Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Published in Clinical cancer research (01-01-2008)“…Purpose: The CD133 antigen has been identified as a putative stem cell marker in normal and malignant brain tissues. In gliomas, it is used to enrich a…”
Get full text
Journal Article -
14
TelomereHunter - in silico estimation of telomere content and composition from cancer genomes
Published in BMC bioinformatics (28-05-2019)“…Establishment of telomere maintenance mechanisms is a universal step in tumor development to achieve replicative immortality. These processes leave molecular…”
Get full text
Journal Article -
15
Macromolecular crowding and its potential impact on nuclear function
Published in Biochimica et biophysica acta (01-11-2008)“…It is well established, that biochemical reactions are dependent on pH, ionic strength, temperature and the concentration of reactants. However, the steric…”
Get full text
Journal Article -
16
The need for a worldwide consensus for cell line authentication: Experience implementing a mandatory requirement at the International Journal of Cancer
Published in PLoS biology (17-04-2017)“…Cell lines are used in life science research worldwide as biological surrogates. All cell lines are subject to major limitations when used as research tools,…”
Get full text
Journal Article -
17
Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme
Published in Nature communications (20-03-2017)“…Mutations in chromatin modifier genes are frequently associated with neurodevelopmental diseases. We herein demonstrate that the chromodomain helicase…”
Get full text
Journal Article -
18
Targeting Self-Renewal in High-Grade Brain Tumors Leads to Loss of Brain Tumor Stem Cells and Prolonged Survival
Published in Cell stem cell (07-08-2014)“…Cancer stem cells (CSCs) have been suggested as potential therapeutic targets for treating malignant tumors, but the in vivo supporting evidence is still…”
Get full text
Journal Article -
19
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Published in Cancer cell (16-08-2011)“…Despite the histological similarity of ependymomas from throughout the neuroaxis, the disease likely comprises multiple independent entities, each with a…”
Get full text
Journal Article -
20
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice
Published in Haematologica (Roma) (01-04-2021)“…Ibrutinib is a bruton's tyrosine kinase (BTK) inhibitor approved for the treatment of multiple B-cell malignancies, including chronic lymphocytic leukemia…”
Get full text
Journal Article